BetazoI Cream contains betamethasone dipropionate 0.05% and miconazole nitrate 2% in a cream base. It is indicated for skin infections with fungi and inflammation. Betamethasone dipropionate is a synthetic corticosteroid that is active against skin inflammations while miconazole nitrate is an antifungal agent with broad-spectrum activity. The cream should be applied once or twice daily for topical treatment.
BetazoI Cream contains betamethasone dipropionate 0.05% and miconazole nitrate 2% in a cream base. It is indicated for skin infections with fungi and inflammation. Betamethasone dipropionate is a synthetic corticosteroid that is active against skin inflammations while miconazole nitrate is an antifungal agent with broad-spectrum activity. The cream should be applied once or twice daily for topical treatment.
BetazoI Cream contains betamethasone dipropionate 0.05% and miconazole nitrate 2% in a cream base. It is indicated for skin infections with fungi and inflammation. Betamethasone dipropionate is a synthetic corticosteroid that is active against skin inflammations while miconazole nitrate is an antifungal agent with broad-spectrum activity. The cream should be applied once or twice daily for topical treatment.
Cream Store below 25° C. COMPOSITION PRESENTATION BetazoI Cream contains Betamethasone BetazoI Cream, 30 g in aluminium collapsible tube. Dipropionate 0.05% w/w and Miconazole Nitrate 2% w/w in a suitable cream base. INDICATIONS Betamethasone Dipropionate in combination with Miconazole Nitrate is indicated for infection of skin with fungi along with inflammation. PHARMACOLOGY Betamethasone Dipropionate is a synthetic fluorinat- ed corticosteroid. It is active against steroid respon- sive dermatoses. Miconazol Nitrate is an antifungal agent with broad-spectrum activity against patho- genic fungi including yeasts and dermatophytes. CONTRAINDICATION Hypersensitivity to any ingredient. WARNING Systemic absorption of topical corticosteroids has resulted in reversible HPA (Hypothalamic-pituitary- adenocortlcal) axis suppression, manifestation of Cushing’s syndrome, hyperglycemia, Systemic Fungal Infection, and glucosuria. Children may absorb larger amounts and be more susceptible to the use of cortico- steroid, and therefore its application in children under 12 years is not advised. ADVERSE REACTION Extended, recurrent application may increase risk of contact sensitization and fungal resistance. Thinning of the skin mild de-pigmentation, acne, irreversible striae atrophicae spread and worsening of untreated infection, impaired wound healing. DOSAGE AND ADMINISTRATION BetazoI Cream, is indicated for topical use applied once or twice a day.